S&P 500
(0.48%) 5 042.49 points
Dow Jones
(0.50%) 38 094 points
Nasdaq
(0.94%) 15 752 points
Oil
(-0.56%) $78.56
Gas
(5.28%) $2.03
Gold
(-0.11%) $2 308.40
Silver
(0.05%) $26.76
Platinum
(0.67%) $961.30
USD/EUR
(0.12%) $0.934
USD/NOK
(0.06%) $11.04
USD/GBP
(0.15%) $0.800
USD/RUB
(-1.62%) $91.75

Realaus laiko atnaujinimai Heska Corp [HSKA]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Medical Devices
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-05-03)

Expected move: +/- 10.42%

Atnaujinta12 birž. 2023 @ 23:00

0.00% $ 119.99

Live Chart Being Loaded With Signals

Commentary (12 birž. 2023 @ 23:00):
Profile picture for Heska Corp

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland...

Stats
Šios dienos apimtis 330 887
Vidutinė apimtis 336 670
Rinkos kapitalizacija 1.31B
EPS $0 ( 2024-02-26 )
Kita pelno data ( $0 ) 2024-05-03
Last Dividend $0.100 ( 2012-09-26 )
Next Dividend $0 ( N/A )
P/E -62.49
ATR14 $0.901 (0.75%)
Insider Trading
Date Person Action Amount type
2023-06-13 Davis Stephen L Sell 500 Common Stock
2023-06-13 Hasenmaier Joachim A. Sell 2 004 Common Stock
2023-06-13 Eyl Steven M. Buy 4 056 Common Stock
2023-06-13 Eyl Steven M. Buy 33 111 Common Stock
2022-02-28 Eyl Steven M. Buy 20 000 Non-Qualified Stock Option (right to buy)
INSIDER POWER
-9.06
Last 100 transactions
Buy: 575 941 | Sell: 596 011

Tūris Koreliacija

Ilgas: 0.40 (neutral)
Trumpas: -0.75 (moderate negative)
Signal:(75.459) Neutral

Heska Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ATCX0.919
BRACU0.916
SYKE0.912
SPRB0.905
XLRN0.905
GRNQ0.902
JFIN0.893
ICON0.89
RDUS0.888
AEYE0.883
10 Labiausiai neigiamai susiję koreliacijos
AHPI-0.894
SBBP-0.887
TUEM-0.88
VIEW-0.872
VERA-0.867
GRPH-0.858
ARDS-0.856
RPTX-0.845
NAKD-0.83
YJ-0.829

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Heska Corp Koreliacija - Valiuta/Žaliavos

The country flag 0.39
( neutral )
The country flag 0.50
( neutral )
The country flag 0.88
( strong )
The country flag 0.76
( moderate )
The country flag -0.88
( strong negative )
The country flag -0.48
( neutral )

Heska Corp Finansinės ataskaitos

Annual 2022
Pajamos: $257.31M
Bruto pelnas: $111.17M (43.20 %)
EPS: $-1.780
FY 2022
Pajamos: $257.31M
Bruto pelnas: $111.17M (43.20 %)
EPS: $-1.780
FY 2021
Pajamos: $253.74M
Bruto pelnas: $105.79M (41.69 %)
EPS: $-0.110
FY 2020
Pajamos: $197.32M
Bruto pelnas: $81.29M (41.20 %)
EPS: $-1.660

Financial Reports:

No articles found.

Heska Corp Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Heska Corp Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.02 - low (0.72%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.100 2012-03-28
Last Dividend $0.100 2012-09-26
Next Dividend $0 N/A
Payout Date 2012-10-10
Next Payout Date N/A
# dividends 3 --
Total Paid Out $0.300 --
Avg. Dividend % Per Year 0.00% --
Score 1.56 --
Div. Sustainability Score 3.02
Div.Growth Potential Score 0
Div. Directional Score 0.0941 --
Next Divdend (Est)
(2024-06-17)
$0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.56
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2012 $0.300 4.08%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.1061.500-2.12-3.18[0 - 0.5]
returnOnAssetsTTM-0.02301.200-0.766-0.920[0 - 0.3]
returnOnEquityTTM-0.03241.500-1.472-2.21[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM5.640.80010.008.00[1 - 3]
quickRatioTTM3.820.80010.008.00[0.8 - 2.5]
cashRatioTTM2.961.50010.0010.00[0.2 - 2]
debtRatioTTM0.185-1.5006.92-10.00[0 - 0.6]
interestCoverageTTM-8.491.000-4.25-4.25[3 - 30]
operatingCashFlowPerShareTTM-1.1862.00-0.395-0.791[0 - 30]
freeCashFlowPerShareTTM-1.4172.00-0.708-1.417[0 - 20]
debtEquityRatioTTM0.262-1.5008.95-10.00[0 - 2.5]
grossProfitMarginTTM0.4291.0006.186.18[0.2 - 0.8]
operatingProfitMarginTTM-0.09201.000-3.84-3.84[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.1131.000-1.737-1.737[0.2 - 2]
assetTurnoverTTM0.2170.800-1.886-1.508[0.5 - 2]
Total Score3.02

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-91.491.000-9.340[1 - 100]
returnOnEquityTTM-0.03242.50-0.946-2.21[0.1 - 1.5]
freeCashFlowPerShareTTM-1.4172.00-0.472-1.417[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.1862.00-0.395-0.791[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.8301.500-8.870[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.09571.000-4.890[0.1 - 0.5]
Total Score-2.83

Heska Corp

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.